Small noncleaved, non-Burkitt's (Burkitt-like) lymphoma: Cytogenetics predict outcome and reflect clinical presentation

Journal of Clinical Oncology

Volumn 17, Issue 5, 1999, Pages 1559-1567

  Macpherson, Nicol ^a   Lesack, David ^a   Klasa, Richard ^a   Horsman, Doug ^a   Connors, Joseph M ^a   Barnett, Michael ^a   Gascoyne, Randy D ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FOLLICULAR LYMPHOMA; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; KARYOTYPE; MALE; ONCOGENE C MYC; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR GROWTH;

EID: 0032921751     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.5.1558     Document Type: Article

References (34)

1. The Non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma. Blood 89:3909-3918, 1997
2. Morrison VA, Frizzera G, Arthur DC, et al: Prognostic factors for therapeutic outcome of diffuse small non-cleaved cell lymphoma in adults. Am J Hematol 46:295-303, 1994
3. Zech L, Haglund U, Nilsson K, et al: Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 17:47-56, 1987
4. Klein G: Comparative action of myc and bcl-2 in B-cell malignancy. Cancer Cells 3:141-143, 1991
5. Coppola JA, Cole MD: Constitutive c-myc oncogene expression blocks mouse erythroleukemia cell differentiation but not commitment. Nature 320:760-763, 1986
6. Griep AE, Westphal H: Anti-sense Myc sequences induce differentiation of F9 cells. Proc Natl Acad Sci U S A 85:6805-6810, 1988
7. Fukuhara S, Rowley JD, Variakojis D: Chromosomal abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res 39:3119-3128, 1979
8. McDonnell TJ, Nunez G, Platt FM, et al: Deregulated bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D expressing B cell population. Mol Cell Biol 10:1901-1907, 1990
9. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the bcl-2 family and cell death. Blood 88:386-401, 1996
10. Brito-Babapulle V, Crawford A, Khokhar T, et al: Translocations t(14;18) and t(8;14) with rearranged bcl-2 and c-myc in a case presenting as B-ALL (L3). Leukemia 5:83-87, 1991
11. Gauwerky CE, Hoxie J, Nowell PC, et al: Pre-B-cell leukemia with a t(8;14) translocation is preceded by follicular lymphoma. Oncogene 2:431-435, 1988
12. deJong D, Voetdijk BMH, Beverstock GC, et al: Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med 318:1373-1378, 1988
13. Matsuzaki H, Hata H, Asou N, et al: Establishment and characterization of acute B-cell lymphocytic leukemia cell line showing (8;14) and (14;18) chromosome translocation. Acta Haematol 84:156-161, 1990
14. Mufti GJ, Hamblin TJ, Oscier DG, et al: Common ALL with pre-B-cell features showing (8;14) and (14;18) chromosomal translocations. Blood 62:1142-1146, 1983
15. Pegoraro L, Palumbo A, Erikson J, et al: A 14;18 and 8;14 translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci U S A 81:971-972, 1984
16. Thangavelu M, Olopade O, Beckman E, et al: Morphologic and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18) (q32;q21) and t(8;14) (q24;q32) or t(8;22) (q24;qll). Genes Chromosom Cancer 2:147-158, 1990
17. Karsan A, Gascoyne RD, Coupland RW, et al: Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies. Leuk Lymphoma 10:433-441, 1993
18. Mitelman F (ed): ISCN 1995: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
19. Fleiss JL: Statistical Methods for Rates and Proportions (ed 2). New York, NY, Wiley, 1991
20. Kaplan EL, Meier P: Non-parametric estimation of incomplete observations. J Am Stat Assoc 53:457-481, 1958
21. Cox DR: Regression models and life-tables. J R Stat Soc B 34:187-202, 1972
22. The International Non-Hodgkin's Lymphoma Prognostic Factor Project: A prediction model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
23. DeVita VT, Canellos GP, Chabner BA, et al: Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1:248-250, 1975
24. Connors JM, Gascoyne R, Hoskins P, et al: ACOP-12:6 dose/12 week chemotherapy for large cell lymphoma: Optimal combination of essential agents and brief treatment. Proc Am Soc Clin Oncol 14:395a, 1995 (abstr)
25. Yano T, van Krieken JHJM, Magrath IT, et al: Histogenetic correlations between subcategories of small noncleaved cell lymphomas. Blood 79:1282-1290, 1992
26. Gaidano G, Pastore C, Gloghini A, et al: Genetic heterogeneity of AIDS-related small non-cleaved cell lymphoma. Br J Haematol 98:726-732, 1997
27. Ladanyi M, Offit K, Parsa NZ, et al: Follicular lymphoma with t(8;14)(q24;q32): A distinct clinical and molecular subset of t(8;14)-bearing lymphomas. Blood 79:2124-2130, 1992
28. Nunez G, London L, Hockenberry D, et al: Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602-3610, 1990
29. Hockenbery D, Nunez G, Milliman C, et al: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
30. Langdon WY, Harris AW, Cory S, et al: The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell 47:11-18, 1986
31. Evan GI, Wyllie AH, Gilbert CS, et al: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128, 1992
32. McDonnell TJ, Deane N, Platt FM, et al: bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular proliferation. Cell 57:79-88, 1989
33. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the (14;18). Nature 349:254-256, 1991
34. Marin MC, Hsu B, Stephens LC, et al: The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp Cell Res 217:240-247, 1995